SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-242045
Filing Date
2019-09-10
Accepted
2019-09-10 16:30:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d784764d424b5.htm 424B5 165975
2 GRAPHIC g784764g30h52.jpg GRAPHIC 39235
3 GRAPHIC g784764g61d79.jpg GRAPHIC 100487
  Complete submission text file 0001193125-19-242045.txt   359464
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233564 | Film No.: 191085643
SIC: 2834 Pharmaceutical Preparations